INGESTIBLE MEDICAL DEVICE HARDWARE

Brand Owner Address Description
BIORA THERAPEUTICS BIORA THERAPEUTICS, INC. 4330 LA JOLLA VILLAGE DRIVE, SUITE 200 SAN DIEGO CA 92122 Ingestible medical device hardware and downloadable software for delivering pharmaceuticals in the gastrointestinal tract in humans; Ingestible medical device hardware and downloadable software for obtaining a human patient specimen sample from the gastrointestinal tract in humans; Ingestible medical device hardware and downloadable software for performing a screening or diagnostic assay on a human patient sample obtained from the gastrointestinal tract; Ingestible medical device hardware and downloadable software for analyzing and reporting results from a screening or diagnostic assay performed on a human patient sample obtained from the gastrointestinal tract;Pharmaceutical formulations for use in combination with ingestible medical device hardware for pharmaceutical delivery in the gastrointestinal tract in humans;Pharmaceutical research and development services utilizing ingestible medical device hardware for delivering pharmaceuticals in the gastrointestinal tract in humans and other mammals for medical purposes; Diagnostic and screening research and development services utilizing ingestible medical device hardware for obtaining a specimen sample from the gastrointestinal tract in humans and other mammals for medical purposes; Performing screening and diagnostic assays on human patient samples obtained from the gastrointestinal tract for medical purposes; Analyzing and reporting results from a screening or diagnostic assay performed on human patient samples obtained from the gastrointestinal tract for medical purposes;Ingestible medical device non-downloadable software for delivering pharmaceuticals in the gastrointestinal tract in humans; Ingestible medical device non-downloadable software for obtaining a human patient specimen sample from the gastrointestinal tract in humans; Ingestible medical device non-downloadable software for performing a screening or diagnostic assay on a human patient sample obtained from the gastrointestinal tract; Ingestible medical device non-downloadable software for analyzing and reporting results from a screening or diagnostic assay performed on a human patient sample obtained from the gastrointestinal tract; Pharmaceutical research and development services utilizing ingestible medical device hardware for delivering pharmaceuticals in the gastrointestinal tract in humans and other mammals for scientific research and analysis purposes; Diagnostic and screening research and development services utilizing ingestible medical device hardware for obtaining a specimen sample from the gastrointestinal tract in humans and other mammals for scientific research and analysis purposes; Performing screening and diagnostic assays on human patient samples obtained from the gastrointestinal tract for scientific research and analysis purposes; Analyzing and reporting results from a screening or diagnostic assay performed on human patient samples obtained from the gastrointestinal tract for scientific research and analysis purposes;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention relates to the use of a supernatant of lactic acid bacteria or of Bifidobacteria capable of preventing colonization of intestinal cells by Giardia intestinalis, for the preparation of an ingestible carrier for the treatment and/or prophylaxis of disorders associated with the colonization of the gut by Giardia intestinalis. The present invention also pertains to specific strains of Bifidobacterium having the above traits and to the ingestible carrier, such as a food or pharmaceutical composition, containing such supernatant or the microorganisms.